Kusakabe Takashi, Kawaguchi Akio, Kawaguchi Rumi, Feigenbaum Lionel, Kimura Shioko
Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Genesis. 2004 Jul;39(3):212-6. doi: 10.1002/gene.20043.
A transgenic mouse line that expresses Cre recombinase under control of the human thyroid peroxidase (TPO) gene promoter was established. The activity and specificity of the TPO-driven Cre recombinase were examined by using Northern blotting and by crossing with the ROSA26 reporter transgenic mouse line. In the latter mice, Cre-mediated recombination occurred only in the thyrocytes, and recombination commenced around embryonic day 14.5, at the time during thyroid organogenesis when TPO expression begins. This study demonstrates that the TPO-Cre transgenic mouse is a powerful tool to specifically delete loxP-inserted (floxed) genes in thyrocytes and will be of great value in the study of thyrocyte-specific genes during development and/or in adult thyroids.
建立了一种在人甲状腺过氧化物酶(TPO)基因启动子控制下表达Cre重组酶的转基因小鼠品系。通过Northern印迹法以及与ROSA26报告基因转基因小鼠品系杂交,检测了TPO驱动的Cre重组酶的活性和特异性。在后者的小鼠中,Cre介导的重组仅发生在甲状腺细胞中,并且重组在胚胎第14.5天左右开始,此时正是甲状腺器官发生过程中TPO表达开始的时候。本研究表明,TPO-Cre转基因小鼠是一种强大的工具,可用于特异性删除甲状腺细胞中loxP插入(floxed)的基因,在发育过程中和/或成年甲状腺中甲状腺细胞特异性基因的研究中将具有重要价值。